Skip to main content

Rhenman & Partners Asset Management AB

Position in LLY — ELI LILLY & Co

CIK 1599882 Stockholm, V7

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$26,765,282
-$4,244,763 QoQ
Shares Held
22,315
-33.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.53%
of 13F equity value
Holder Rank
#763
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. LLY ranks #3 (15.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 LLY
ELI LILLY & Co
This page
22,315 $26,765,282

All Filings in LLY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,765,282 22,315
2026-03-31 $31,010,045 33,715
2025-12-31 $45,372,993 42,220
2025-09-30 $40,759,460 53,420
2025-06-30 $45,111,401 57,870
2025-03-31 $34,481,742 41,750
2024-12-31 $35,087,400 45,450
2024-09-30 $42,082,150 47,500
2024-06-30 $42,552,860 47,000
2024-03-31 $42,145,983 54,175
2023-12-31 $45,470,674 78,005
2023-09-30 $53,713,000 100,000
2023-06-30 $37,987,380 81,000
2022-12-31 $32,193,920 88,000
2022-09-30 $31,364,950 97,000
2022-06-30 $29,180,700 90,000
2022-03-31 $35,366,695 123,500
2021-12-31 $46,957,400 170,000
2021-09-30 $33,502,250 145,000
2021-06-30 $27,266,976 118,800
2021-03-31 $31,759,400 170,000
2020-12-31 $30,391,200 180,000
2020-09-30 $24,423,300 165,000
2020-06-30 $17,238,900 105,000
2020-03-31 $13,872,000 100,000